Bryce Beverlin II

Quench Medical, Inc.

$5,631,185

Attributed

$5,631,185

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.6M · FY2018–25

$2M$1.5M$1M$500K$0

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$5,631,185 · 7

By mechanism

R44$4,051,771 · 2

R43$1,329,599 · 4

SB1$249,815 · 1

Top collaborators

No co-investigators on record.

Others in their field

Other Emerging Leaders on “Formulation”

Matthew Johnson · Duke University$56,071,536
Susan Abushakra · Alzheon, Inc.$47,690,244
Xinhua Li · Nano Terra, Inc.$35,520,438
Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
Jay Evans · University Of Montana$27,950,292
Kristin Aillon · Midwest Research Institute$24,965,877

Research focus

FormulationProductionInhalationPre-ClinicalAerosolsPowder Dose FormPharmaceutical PreparationsLungFirst-In-HumanTranslationsClinical ResearchPharyngeal StructureCharacteristicsExcipientsTechnologyGrowthDoseDepositionInvestigational DrugsIn VivoToxicologyDrug Delivery SystemsEfficacy StudyLead